Skip to main navigation Skip to search Skip to main content

Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation

  • Margaret A. Park
  • , Guo Zhang
  • , Aditi Pandya Martin
  • , Hossein Hamed
  • , Clint Mitchell
  • , Philip B. Hylemon
  • , Martin Graf
  • , Mohamed Rahmani
  • , Kevin Ryan
  • , Xiang Liu
  • , Sarah Spiegel
  • , James Norris
  • , Paul B. Fisher
  • , Steven Grant
  • , Paul Dent
  • Virginia Commonwealth University
  • Beatson Institute for Cancer Research
  • Medical University of South Carolina
  • Virginia Commonwealth University
  • Virginia Commonwealth University Health System

Research output: Contribution to journal › Article › peer-review

164 Scopus citations

Fingerprint

Dive into the research topics of 'Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation'. Together they form a unique fingerprint.
Sort by

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science